Clinical performance of the APTIMA® HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

This publication has 38 references indexed in Scilit:

• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  Published by Elsevier ,2007
• Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer
  New England Journal of Medicine, 2007
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006
• Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis
  The Lancet, 2005
• Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer
  Cancer Epidemiology, Biomarkers & Prevention, 2005
• Interim Guidance for the Use of Human Papillomavirus DNA Testing as an Adjunct to Cervical Cytology for Screening
  Obstetrics & Gynecology, 2004
• Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
  New England Journal of Medicine, 2003
• Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study
  BMJ, 2002
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
  The Journal of Pathology, 1999
• Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
  JNCI Journal of the National Cancer Institute, 1993